Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence.

Di Caro G, Marchesi F, Galdiero MR, Grizzi F.

Expert Rev Mol Diagn. 2014 Apr;14(3):387-99. doi: 10.1586/14737159.2014.900443. Review.

PMID:
24649823
2.

Noninvasive screening tests for colorectal cancer.

Imperiale TF.

Dig Dis. 2012;30 Suppl 2:16-26. doi: 10.1159/000341884. Review.

PMID:
23207928
3.

A combination of serum markers for the early detection of colorectal cancer.

Wild N, Andres H, Rollinger W, Krause F, Dilba P, Tacke M, Karl J.

Clin Cancer Res. 2010 Dec 15;16(24):6111-21. doi: 10.1158/1078-0432.CCR-10-0119.

4.

Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.

Ladabaum U, Allen J, Wandell M, Ramsey S.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1567-76. doi: 10.1158/1055-9965.EPI-13-0204.

5.

Faecal immunochemical tests: a valuable tool for colorectal cancer screening.

Lepage C, Hamza S.

Dig Liver Dis. 2012 Aug;44(8):629-30. doi: 10.1016/j.dld.2012.05.015. No abstract available.

PMID:
22687627
6.
7.

Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.

Atreya I, Neurath MF.

Expert Rev Anticancer Ther. 2008 Apr;8(4):561-72. doi: 10.1586/14737140.8.4.561. Review.

PMID:
18402523
8.

Novel serum nucleosomics biomarkers for the detection of colorectal cancer.

Holdenrieder S, Dharuman Y, Standop J, Trimpop N, Herzog M, Hettwer K, Simon K, Uhlig S, Micallef J.

Anticancer Res. 2014 May;34(5):2357-62.

PMID:
24778043
9.

Assessment of novel combinations of biomarkers for the detection of colorectal cancer.

Shimwell NJ, Wei W, Wilson S, Wakelam MJ, Ismail T, Iqbal T, Johnson PJ, Martin A, Ward DG.

Cancer Biomark. 2010;7(3):123-32. doi: 10.3233/CBM-2010-0155.

PMID:
21263188
10.

Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.

Chen H, Werner S, Tao S, Zörnig I, Brenner H.

Cancer Lett. 2014 May 1;346(2):178-87. doi: 10.1016/j.canlet.2014.01.007. Review.

PMID:
24462820
11.

Biological and clinical markers in colorectal cancer: state of the art.

Cappellani A, Di Vita M, Zanghi A, Veroux P, Cavallaro A, Lo Menzo E, Cacopardo B, Canzonieri V, Murabito P, Tirelli U, Berretta M.

Front Biosci (Schol Ed). 2010 Jan 1;2:422-31. Review.

PMID:
20036958
12.

Serum tests for colorectal cancer screening.

Creeden J, Junker F, Vogel-Ziebolz S, Rex D.

Mol Diagn Ther. 2011 Jun 1;15(3):129-41. doi: 10.2165/11591300-000000000-00000. Review.

PMID:
21766904
13.

Effector memory T cells, early metastasis, and survival in colorectal cancer.

Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J.

N Engl J Med. 2005 Dec 22;353(25):2654-66.

14.

Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.

Faivre J, Dancourt V, Manfredi S, Denis B, Durand G, Gendre I, Bidan JM, Jard C, Levillain R, Jung S, Viguier J, Dorval E.

Dig Liver Dis. 2012 Aug;44(8):700-4. doi: 10.1016/j.dld.2012.03.015.

PMID:
22542582
15.

Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.

Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, Ofner A, Crispin A, Neumann J, Lamerz R, Kolligs FT.

Am J Gastroenterol. 2011 Jun;106(6):1110-8. doi: 10.1038/ajg.2011.6.

PMID:
21326223
16.

Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

de Wit M, Fijneman RJ, Verheul HM, Meijer GA, Jimenez CR.

Clin Biochem. 2013 Apr;46(6):466-79. doi: 10.1016/j.clinbiochem.2012.10.039. Review.

PMID:
23159294
17.

Molecular tests for colorectal cancer screening.

Bosch LJ, Carvalho B, Fijneman RJ, Jimenez CR, Pinedo HM, van Engeland M, Meijer GA.

Clin Colorectal Cancer. 2011 Mar 1;10(1):8-23. doi: 10.3816/CCC.2011.n.002. Review.

PMID:
21609931
18.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

19.

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB.

BMC Immunol. 2010 Apr 12;11:19. doi: 10.1186/1471-2172-11-19.

20.

Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.

Chang W, Wu L, Cao F, Liu Y, Ma L, Wang M, Zhao D, Li P, Zhang Q, Tan X, Yu Y, Lou Z, Zhao J, Zhang H, Fu C, Cao G.

Clin Cancer Res. 2011 Sep 1;17(17):5715-24. doi: 10.1158/1078-0432.CCR-11-0199.

Items per page

Supplemental Content

Support Center